Correlation Between Genetic Technologies and HTG Molecular

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genetic Technologies and HTG Molecular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genetic Technologies and HTG Molecular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genetic Technologies and HTG Molecular Diagnostics, you can compare the effects of market volatilities on Genetic Technologies and HTG Molecular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genetic Technologies with a short position of HTG Molecular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genetic Technologies and HTG Molecular.

Diversification Opportunities for Genetic Technologies and HTG Molecular

-0.64
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Genetic and HTG is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Genetic Technologies and HTG Molecular Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HTG Molecular Diagnostics and Genetic Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genetic Technologies are associated (or correlated) with HTG Molecular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HTG Molecular Diagnostics has no effect on the direction of Genetic Technologies i.e., Genetic Technologies and HTG Molecular go up and down completely randomly.

Pair Corralation between Genetic Technologies and HTG Molecular

If you would invest  35.00  in HTG Molecular Diagnostics on February 2, 2024 and sell it today you would earn a total of  0.00  from holding HTG Molecular Diagnostics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy2.38%
ValuesDaily Returns

Genetic Technologies  vs.  HTG Molecular Diagnostics

 Performance 
       Timeline  
Genetic Technologies 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Genetic Technologies are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Genetic Technologies exhibited solid returns over the last few months and may actually be approaching a breakup point.
HTG Molecular Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HTG Molecular Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, HTG Molecular is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Genetic Technologies and HTG Molecular Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genetic Technologies and HTG Molecular

The main advantage of trading using opposite Genetic Technologies and HTG Molecular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genetic Technologies position performs unexpectedly, HTG Molecular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HTG Molecular will offset losses from the drop in HTG Molecular's long position.
The idea behind Genetic Technologies and HTG Molecular Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets